Chimeric Therapeutics Limited (ASX:CHM)
0.0040
0.00 (0.00%)
Jun 17, 2025, 11:34 AM AEST
Chimeric Therapeutics Market Cap
Chimeric Therapeutics has a market cap or net worth of 8.06 million as of June 16, 2025. Its market cap has decreased by -67.54% in one year.
Market Cap
8.06M
Enterprise Value
2.99M
Revenue
2.04M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.00
Market Cap Chart
Since January 18, 2021, Chimeric Therapeutics's market cap has decreased from 97.50M to 8.06M, a decrease of -91.73%. That is a compound annual growth rate of -43.17%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jun 16, 2025 | 8.06M | -26.88% |
Dec 31, 2024 | 11.02M | -56.60% |
Dec 29, 2023 | 25.40M | -27.35% |
Dec 30, 2022 | 34.97M | -59.93% |
Dec 31, 2021 | 87.26M | -10.51% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
CSL Limited | 115.66B |
Pro Medicus | 28.26B |
Cochlear | 17.84B |
Sonic Healthcare | 12.91B |
Ramsay Health Care | 8.52B |
Telix Pharmaceuticals | 8.38B |
Ansell | 4.45B |
Mesoblast | 2.29B |